HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
INSIDE INDUSTRY
BioScience Managers expands Asia Pacific presence
Leading Asia Pacific healthcare fund manager, BioScience Managers Pty Ltd, announced a $3m investment in innovative New Zealand asthma technology company, Nexus6.

Nexus6's SmartInhaler product remotely monitors adherence to asthma treatment regimes, ensuring patients comply with treatment protocols in general use and in clinical trials, giving clinicians transparency over inhaler use and dosage in real time.

“Nexus6 technology holds the key to not only ensuring better patient outcomes, but also in minimizing wastage and costs of treatment, by ensuring that asthma sufferers take only what they need and when they need it,” said BioScience Managers Managing Director, Jeremy Curnock Cook.

“In the current climate, technologies that enable remote monitoring of patients and support the delivery of better health outcomes, for less cost and with less wastage, are extremely important. Nexus6 also provides a unique supporting technology for asthma clinical trials.”

Nexus6 marks BioScience Managers’ second investment from its Asia Pacific Healthcare Fund II. The AU$55m fund is still open to investors, with a final close expected in September 2013. The investment was also supported by up to $2m raised from existing investors, including leading NZ venture firm K1W1.

The firm is increasingly active in the medical technologies space, providing investment management services to Plus listed UnionMedtech (UMT). UMT marks the first of a planned series of tailored investment vehicles to bring together investor appetite for specific aspects of healthcare with technologies sourced from around the globe.

BioScience Managers Chief Investment Officer Matt McNamara commented, “The healthcare sector is increasingly important at a global macroeconomic level, with both the cost and the effectiveness of healthcare solutions coming under increasing scrutiny.”

“We believe there is a significant opportunity in the investment in and consolidation of medical technologies from around the world to enable those companies better access to international markets and economies of scale across synergistic businesses.”

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017: Industry players optimistic of future
news Nestlé Introduces their Singapore R&D Centre
news Vitafoods Asia Elevates 2017 Learning Programme
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy